Brief: Kissei Pharmaceutical: Signed Technology Licensing Agreement With Taiwan's Synmosa Biopharma Over Gnrh Antagonist 'Linzagolix'

Kissei Pharmaceutical

02/11/2022 06:25

Nov 2 (Reuters) - Synmosa Biopharma Corp  4114.TWO :
    * KISSEI PHARMACEUTICAL: SIGNED TECHNOLOGY LICENSING
AGREEMENT
WITH TAIWAN'S SYNMOSA BIOPHARMA OVER GNRH ANTAGONIST
'LINZAGOLIX'

Further company coverage:  4114.TWO  4547.T 
 (Reporting by Tokyo Newsroom)
 ((+81345201189;))